Cambridge Enterprise Seed Funds and Cambridge Innovation Capital have invested in Carrick Therapeutics, a company commercialising research from Cambridge and Oxford universities and Imperial College London.

Relay Therapeutics emerged last week with $57m in funding to support the development of cancer therapies based on a new understanding of how protein molecules undergo changes.

DE Shaw Research has backed a series A round for Relay Therapeutics, launched yesterday to commercialise research from Shaw and a range of universities.

Allergan has acquired the Wayne State University spinout, backed by Santen Pharmaceutical and Nerveda, for an upfront payment of $60m with potential milestone payments in future.

Lundbeck-backed Iconic Therapeutics, which aims to apply tissue factor biology to retinal disease and cancer treatments, has now raised $80m altogether.

The incubator and workspace provider has secured capital from a consortium featuring return investor University Ventures.

Tioma Therapeutics, an oncology treatment spinout of Washington University in St Louis, has secured funding from backers including Novo, GlaxoSmithKline and Roche.

Johnson & Johnson invested $6m to help radiotherapy equipment developer Reflexion Medical close out its Pfizer-backed series B round at $52m.

Celgene has supported a funding round for Oncorus, an immuno-oncology treatment developer exploiting research conducted at Pittsburgh.